Galapagos NV ADR (GLPG)
US$ 27.06-1.46%
Price Chart
Key Statistics
Market Cap
$ 1.73B
P/E Ratio
0.00
Revenue (TTM)
$ 288.19M
Volume
250.91K
52W High
$ 31.23
52W Low
$ 22.36
Dividend Yield
0.00%
Beta
-0.06
Technicals
50-Day MA
25.552
200-Day MA
26.6656
52 Week High
31.225
52 Week Low
22.36
About GLPG
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has comp.
Employees
704
Headquarters
Mechelen, Belgium
CEO
Dr. Paulus A. Stoffels M.D., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg